BioSpace News Archive

PreveCeutical Medical Inc. (CSE: PREV) (OTCQB: PRVCF) (FSE: 18H) (the “Company” or “PreveCeutical”) is pleased to announce the full independent peer-reviewed publication of an article on the design and development of its non-addictive analgesic program (“Analgesic Program”).

Results of a comprehensive review of published scientific literature comparing data associated with various DNA vaccine delivery methods will be presented at the World Vaccine Congress 2023 on April 5, 2023 at 5:10 pm ET.

Onera Health, a leader in transforming sleep medicine and remote monitoring, today announced an exclusive strategic partnership with MedBridge Healthcare, a leading provider of sleep management services including sleep screening, in-center, inpatient and home diagnostic testing and therapy coordination.

VBI Vaccines Inc. announced plans to focus the Company’s efforts on the fight against hepatitis B, concentrating on broadening access to VBI’s FDA-approved 3-antigen HBV vaccine for adults, PreHevbrio™ [Hepatitis B Vaccine ], and advancing its HBV immunotherapeutic candidate, VBI-2601, which has the potential to be part of a functional cure regimen for chronic HBV patients.

Inozyme Pharma, Inc. announced the grant of an inducement award outside of the Company’s 2020 Stock Incentive Plan to its newly appointed Chief Operations Officer, Matthew Winton, Ph.D.

Neuronetics, Inc. provided a corporate update which includes entering into a new credit facility with investment affiliates managed by SLR Capital Partners, LLC and providing Greenbrook TMS with a promissory note as part of an updated TMS device supply agreement.

Carisma Therapeutics Inc. (Nasdaq: CARM), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today reported financial results for the year ended December 31, 2022 and highlighted recent business updates.

Stratasys Ltd. and CollPlant Biotechnologies announced a joint development and commercialization agreement to collaborate on the development of a solution to bio-fabricate human tissues and organs using Stratasys’ P3 technology-based bioprinter and CollPlant’s rh-Collagen-based bioinks.

BioPhotas, Inc., the manufacturer of the award-winning Celluma SERIES of light therapy devices, announced today that the Company received certification to European Council Medical Device Regulation 2017/745 for low level light therapy devices.

AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that chief executive officer Hans S. Keirstead, Ph.D. will chair a keynote panel and talk at the World Vaccine Congress taking place April 3-6 in Washington, D.C.